Cambridge Advisors Inc. Charles River Laboratories International, Inc. Transaction History
Cambridge Advisors Inc.
- $446 Million
- Q3 2024
A detailed history of Cambridge Advisors Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Cambridge Advisors Inc. holds 1,200 shares of CRL stock, worth $223,548. This represents 0.05% of its overall portfolio holdings.
Number of Shares
1,200
Previous 1,200
-0.0%
Holding current value
$223,548
Previous $247,000
4.45%
% of portfolio
0.05%
Previous 0.06%
Shares
5 transactions
Others Institutions Holding CRL
# of Institutions
695Shares Held
52.2MCall Options Held
259KPut Options Held
463K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.14 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$948 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.74MShares$697 Million0.13% of portfolio
-
State Street Corp Boston, MA2.13MShares$397 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.94MShares$361 Million0.87% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $9.48B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...